EQS — News: MetaTech AP Unveils 2027 Growth Strategy, Partners with Zheng Yang Biomedical to Build a Regenerative Medicine Supply Chain

EQS-News: MetaTech AP Inc. / Key word(s): Forecast MetaTech AP Unveils 2027 Growth Strategy, Partners with Zheng Yang Biomedical to Build a Regenerative Medicine Supply Chain 15.10.2026 / 12:10 CET/CEST The issuer is solely responsible for the content of this announcement. ════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════════ TAIPEI, Oct. 15, 2026 // — MetaTech AP Inc. (TPEx: 3224) held its investor conference today, presenting its 2026 operating performance and strategic outlook for 2027. Revenue for the first nine months of 2026 reached NT$1.391 billion, representing 21% year-over-year growth. With electronics and biomedicine serving as its two growth engines, MetaTech AP is actively expanding its presence in the global AI supply chain and regenerative medicine market. 1 MetaTech (AP) Inc. (TPEx 3224) held its investor conference on October 15, 2026. Pictured from left Alex Chen, Chairman of MetaTech (AP) Inc., and Sebastian Tseng, Chairman of Zheng Yang Biomedical Technology Co., Ltd. (ZYBT). Steady Electronics Growth and Progress in